Jian Shen

Oct 28, 2024 | mdpi.com | Ye Zhu |Tao Jiang |Jian Shen

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Oct 23, 2024 | pubs.acs.org | Feng Hao |Rui Song |Jie Yang |Jian Shen

Jul 23, 2024 | nature.com | Wentao Jiang |Jian Shen |Chun Mao |Min Zhou

Correction to: Nature Nanotechnology https://doi.org/10.1038/s41565-024-01681-7, published online 27 May 2024. In the version of this article originally published online, in the color key to Fig. 4h, “7. CM/NM/Mito i.v. (5 times)” should have been “7. CM/NM/Mito@Cap (5 times)”, and “8. CM/NM/Mito@Cap (5 times)” should have been “8. CM/NM/Mito i.v. (5 times)”.

May 27, 2024 | nature.com | Wentao Jiang |Jian Shen |Chun Mao |Min Zhou

AbstractMitochondrial transplantation is an important therapeutic strategy for restoring energy supply in patients with ischaemic heart disease (IHD); however, it is limited by the invasiveness of the transplantation method and loss of mitochondrial activity. Here we report successful mitochondrial transplantation by oral administration for IHD therapy.

Jan 12, 2024 | pubs.rsc.org | Lin Chen |Wenyan Guo |Chun Mao |Jian Shen

Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents Liver fibrosis is a reversible damage-repair response, whose pathological features mainly include damage of hepatocytes, sinusoid capillarization, hepatic stellate cells (HSCs) activation, excessive accumulation of extracellular matrix (ECM) and inflammatory response.